Company intelligence / Profile preview

Kestra Medical Technologies

Kirkland, Washington, United Stateskestramedical.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

The ASSURE Wearable Cardioverter Defibrillator system has demonstrated a significant reduction in false alarms compared to legacy devices and high compliance rates. Over 17,000 patients have used the system since its commercial launch. The device delivers effective defibrillation therapy for SCA with a median daily wear time of over 23 hours and established reimbursement across major US insurers.

Therapeutic areas: Cardiovascular
Modalities: DeviceDigital health solutionWearable medical device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

ASSURE

Commercial

Indications: Sudden Cardiac Arrest, Heart Failure

Partnerships

Broad partnerships with major US insurers including Cigna, Premera Blue Cross Blue Shield plans etc.Hospital networks (>550 hospitals prescribing)

Beyond the preview

Go deeper on Kestra Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kestra Medical Technologies.

Explore the full profile